o. Univ.-Prof. Dr. med.

Michael Gnant , FACS

Michael Gnant

Corresponding Member of the Division of Mathematics and the Natural Sciences in Austria since 2017

  • Universitätsklinik für Chirurgie, Medizinische Universität Wien

Contact:

Orcid-ID:

0000-0003-1002-2118

Research Areas:

  • Clinical Medicine
  • Oncological surgery
  • Allergology
  • Cancer research
  • Experimental surgery
  • Transplant surgery

Profile:

CV/Website

Selected Memberships:

  • American College of Surgeons
  • American Society of Clinical Oncology
  • American Society of Cancer Research
  • Breast International Group
  • Österreichische Gesellschaft für Chirurgische Onkologie
  • St. Gallen International Breast Cancer Conference
  • European Organisation for Research and Treatment of Cancer

Selected Prizes:

  • Claudia von Schilling Preis
  • Theodor-Billroth-Preis der Ärztekammer für Wien
  • Martin Research Prize of the Massachusetts General Hospital
  • Großer Zentraleuropäischer Preis der Stadt Wien für Interdisziplinäre Krebsforschung
  • Großes Ehrenzeichen der Ärztekammer für Wien

Selected Publications:

  • Gnant, Michael; Harbeck, Nadia (2017, online: 2016) Breast Cancer. Lancet, Bd. 389 (10074), S. 1134-1150.
  • Gnant, Michael et al. (2015) Adjuvant denosumab in breast cancer - a multicentre, randomised, double-blind, placebo-controlled trial (ABCSG-18). Lancet, Bd. 386 (9992), S. 433-443.
  • Gnant, Michael et al. (2013) Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 score in 1,478 postmenopausal patients of the ABCSG-08 trial treated with adjuvant endocrine therapy alone. Annals of Oncology, Bd. 25 (2), S. 339-345.
  • Gnant, Michael et al. (2012) Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. New England Journal of Medicine, Bd. 366 (6), S. 520-529.
  • Gnant, Michael; Steger, Günther G. (2009) Fighting overtreatment in adjuvant breast cancer therapy. Lancet, Bd. 374 (9707), S. 2029-2030.
  • Gnant, Michael et al. (2009) Adjuvant endocrine therapy plus zoledronic acid in premenopausal breast cancer. New England Journal of Medicine, Bd. 360 (7), S. 679-691.